Summary
The product Trenbolone Acetate, manufactured by Hilma Biocare, underwent analysis to verify its composition and potency. The sample, submitted and funded by hilmabiocare.com, was analyzed by Janoshik Analytical, a laboratory known for its rigorous pharmaceutical testing. The analysis confirmed the presence of Trenbolone Acetate at a measured concentration of 99.70 mg/ml, slightly below the labeled specification of 100 mg/ml by 0.3%.
The testing process was initiated on 23 October 2023, with the sample received on 27 October 2023, and the analysis completed on 29 October 2023. While the results indicate high dosing accuracy, the sample’s submission by the manufacturer warrants additional scrutiny to account for potential biases. Independent third-party testing of market-acquired samples would strengthen confidence in the product’s consistency across batches.
Detailed Report
Product Overview
- Manufacturer: Hilma Biocare
- Product Name: Trenbolone Acetate
- Active Ingredient: Trenbolone Acetate
- Batch Number: Trenbolone Acetate – 062215
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #34754
- Testing Ordered: 23 October 2023
- Sample Received: 27 October 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: hilmabiocare.com (Manufacturer)
- Analysis Paid For By: hilmabiocare.com
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 99.70 mg/ml
- Accuracy: 99.7% (0.3% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/34754_RDZXE2ME3BZP
- Originally Published: https://thinksteroids.com/community/posts/3227892/
Evaluation of Manufacturer-Submitted Testing
This report highlights exceptional accuracy in dosing for the tested product, reflecting a variance of just 0.3% below the label claim. However, the testing was both submitted and funded by the manufacturer, hilmabiocare.com, which introduces the potential for selective sample submission. While the findings bolster confidence in the manufacturing process, independent testing of random market-purchased samples would provide a more comprehensive evaluation of the product’s consistency and quality.
Conclusion
The analysis of Trenbolone Acetate demonstrates excellent adherence to the labeled specification, with a minimal variance of 0.3%. This consistency underscores the manufacturer’s quality control efforts. However, transparency and independent corroboration remain crucial to fully validate these findings. This report aims to provide educational insights to promote harm reduction and informed consumer choices.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases due to selective batch submissions. The findings pertain solely to the tested batch and do not generalize to all products under the same name. Readers are encouraged to cross-reference these results with independent third-party testing and use this information responsibly.
